Fidelity Investments’s Yield10 Bioscience, Inc. Common Stock YTEN Stock Holding History

Fidelity Investments’s Portfolio YTEN Stock Details YTEN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-59	Closed	-$3.12K	–	5578
2023 Q2	$3.12K	Buy	+59	New	+$3.84K	﹤0.01%	4486
2015 Q4	–	Sell	-9	Closed	-$115K	–	2787
2015 Q3	$115K	Hold	9	–	–	﹤0.01%	2697
2015 Q2	$326K	Sell	9 -22	-71%	-$905K	﹤0.01%	2652
2015 Q1	$1.1M	Sell	31 -3	-9%	-$96K	﹤0.01%	2503
2014 Q4	$792K	Sell	34 -1	-3%	-$34.3K	﹤0.01%	2578
2014 Q3	$1.85M	Sell	35 -10	-22%	-$432K	﹤0.01%	2443
2014 Q2	$2.23M	Sell	45 -6	-12%	-$338K	﹤0.01%	2392
2014 Q1	$3.82M	Hold	51	–	–	﹤0.01%	2262
2013 Q4	$3.7M	Buy	51 +1	+2%	+$67K	﹤0.01%	2240
2013 Q3	$3.61M	Hold	50	–	–	﹤0.01%	2235
2013 Q2	$4.07M	Buy	+50	New	+$4.83M	﹤0.01%	2183

Other funds holding YTEN

Cannell & Co New York $3.15B AUM 30.62% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

CCB

Cutter & Co Brokerage Ballwin, Missouri $423M AUM 15.02% 1-Year Est. Return

WAM

Warberg Asset Management Winnetka, Illinois $600M AUM 23.37% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Birchview Capital Burlington, Vermont $176M AUM 95.04% 1-Year Est. Return

Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return

Fidelity Investments's YTEN Position: Q3 2023 in Review

Fidelity Investments sold out of Yield10 Bioscience, Inc. Common Stock (YTEN) in Q3 2023, closing a stake of 59 shares — an estimated $3.12K sold.

Fidelity Investments first reported a position in YTEN in Q2 2013 and held it in 11 quarters. The position peaked at $4.07M in Q2 2013. 15 funds tracked by Wall St. Rank hold YTEN as of Q3 2023.

Fidelity Investments reported no remaining Yield10 Bioscience, Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
Fidelity Investments sold 59 Yield10 Bioscience, Inc. Common Stock shares in Q3 2023, an estimated $3.12K.
Fidelity Investments first reported a position in Yield10 Bioscience, Inc. Common Stock in Q2 2013 and held it in 11 quarters.
Fidelity Investments's Yield10 Bioscience, Inc. Common Stock position peaked at $4.07M in Q2 2013.
15 funds tracked by Wall St. Rank held Yield10 Bioscience, Inc. Common Stock as of Q3 2023.

Based on Fidelity Investments's 13F filing for Q3 2023, filed 13 Nov 2023.